NCT05337345 A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants Status COMPLETED Phase PHASE1
NCT05337137 A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT05335031 A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®) Status COMPLETED Phase N/A
NCT05334719 A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer Status COMPLETED Phase N/A
NCT05328908 A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer Status TERMINATED Phase PHASE3
NCT05326620 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) Status RECRUITING Phase N/A
NCT05324436 A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) Status COMPLETED Phase N/A
NCT05320094 A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants Status COMPLETED Phase PHASE1
NCT05319093 Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients Status TERMINATED Phase N/A
NCT05308966 Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) Status COMPLETED Phase N/A
NCT05304533 A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy Participants Status COMPLETED Phase PHASE1
NCT05303220 A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants Status COMPLETED Phase PHASE1
NCT05303051 Validation of the Diabetes Deep Neural Network Score for Diabetes Mellitus Screening Status WITHDRAWN Phase NA
NCT05302921 Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors Status COMPLETED Phase PHASE2
NCT05301972 Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor Status NO_LONGER_AVAILABLE Phase N/A
NCT05298592 A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors Status COMPLETED Phase PHASE1
NCT05297565 A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection Status COMPLETED Phase PHASE3
NCT05289492 Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1